Interplay between population dynamics and drug tolerance of staphylococcus aureus persister cells

Journal of Molecular Microbiology and Biotechnology

Volumn 22, Issue 6, 2013, Pages 381-391

  Lechner, Sabrina ^a   Patra, Pintu ^b   Klumpp, Stefan ^b   Bertram, Ralph ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

Author keywords

Antibiotics; Antimicrobials; Multi drug tolerance; Persister cells; Population dynamics; Staphylococcus aureus

Indexed keywords

CALCIUM; CIPROFLOXACIN; DAPTOMYCIN; RIFAMPICIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CELL; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS TOLERANCE; DRUG EXPOSURE; MATHEMATICS; MICROBIAL POPULATION DYNAMICS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERSISTER CELL; PHENOTYPE; STAPHYLOCOCCUS AUREUS; STOCHASTIC MODEL;

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; COLONY COUNT, MICROBIAL; DAPTOMYCIN; DRUG TOLERANCE; MICROBIAL VIABILITY; MODELS, THEORETICAL; POPULATION DYNAMICS; STAPHYLOCOCCUS AUREUS; TOBRAMYCIN;

STAPHYLOCOCCUS AUREUS;

EID: 84873023528     PISSN: 14641801     EISSN: 16602412     Source Type: Journal    
DOI: 10.1159/000346073     Document Type: Article

References (38)

1. Allison KR, Brynildsen MP, Collins JJ: Heterogeneous bacterial persisters and engineering approaches to eliminate them. Curr Opin Microbiol 2011; 14: 593-598.
2. Balaban NQ: Persistence: mechanisms for triggering and enhancing phenotypic variability. Curr Opin Genet Dev 2011; 21: 768-775.
3. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S: Bacterial persistence as a phenotypic switch. Science 2004; 305: 1622-1625.
4. Bigger J: Treatment of staphylococcal infections with penicillin. Lancet 1944; 244: 497-500.
5. Buerger S, Spoering A, Gavrish E, Leslin C, Ling L, Epstein SS: Microbial scout hypothesis, stochastic exit from dormancy, and the nature of slow growers. Appl Environ Microbiol 2012; 78: 3221-3228.
6. Cataudella I, Trusina A, Sneppen K, Gerdes K, Mitarai N: Conditional cooperativity in toxin- antitoxin regulation prevents random toxin activation and promotes fast translational recovery. Nucleic Acids Res 2012, Epub ahead of print.
7. Davidson RJ, Zhanel GG, Phillips R, Hoban DJ: Human serum enhances the postantibiotic effect of fluoroquinolones against Staphylococcus aureus . Antimicrob Agents Chemother 1991; 35: 1261-1263.
8. Dhar N, McKinney JD: Microbial phenotypic heterogeneity and antibiotic tolerance. Curr Opin Microbiol 2007; 10: 30-38.
9. Drusano GL: Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'. Nat Rev Microbiol 2004; 2: 289-300.
10. Dworkin J, Shah IM: Exit from dormancy in microbial organisms. Nat Rev Microbiol 2010; 8: 890-896.
11. Gefen O, Balaban NQ: The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress. FEMS Microbiol Rev 2009; 33: 704-717.
12. Gefen O, Gabay C, Mumcuoglu M, Engel G, Balaban NQ: Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria. Proc Natl Acad Sci USA 2008; 105: 6145-6149.
13. Hanberger H, Nilsson LE, Maller R, Isaksson B: Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca 2+ and albumin on these drugs. Antimicrob Agents Chemother 1991; 35: 1710-1716.
14. Iordanescu S, Surdeanu M: Two restriction and modification systems in Staphylococcus aureus NCTC8325. J Gen Microbiol 1976; 96: 277-281.
15. Isaksson B, Maller R, Nilsson LE, Nilsson M: Postantibiotic effect of aminoglycosides on staphylococci. J Antimicrob Chemother 1993; 32: 215-222.
16. Jõers A, Kaldalu N, Tenson T: The frequency of persisters in Escherichia coli reflects the kinetics of awakening from dormancy. J Bacteriol 2010; 192: 3379-3384.
17. Kaldalu N, Mei R, Lewis K: Killing by ampicillin and ofloxacin induces overlapping changes in Escherichia coli transcription profile. Antimicrob Agents Chemother 2004; 48: 890-896.
18. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K: Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 2004a;230: 13-18.
19. Keren I, Minami S, Rubin E, Lewis K: Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. MBio 2011; 2:e00100-e00111.
20. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K: Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli . J Bacteriol 2004b;186: 8172-8180.
21. Kussell E, Kishony R, Balaban NQ, Leibler S: Bacterial persistence: a model of survival in changing environments. Genetics 2005; 169: 1807-1814.
22. Kussell E, Leibler S: Phenotypic diversity, population growth, and information in fluctuating environments. Science 2005; 309: 2075-2078.
23. Lechner S, Lewis K, Bertram R: Staphylococcus aureus persisters tolerant to bactericidal antibiotics. J Mol Microbiol Biotechnol 2012; 22: 235-244.
24. Lewis K: Persister cells, dormancy and infectious disease. Nat Rev Microbiol 2007; 5: 48-56.
25. Lewis K: Persister cells. Annu Rev Microbiol 2010; 64: 357-372.
26. Maisonneuve E, Shakespeare LJ, Jørgensen MG, Gerdes K: Bacterial persistence by RNA endonucleases. Proc Natl Acad Sci USA 2011; 108: 13206-13211.
27. Massey RC, Buckling A, Peacock SJ: Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus . Curr Biol 2001; 11: 1810-1814.
28. Möker N, Dean CR, Tao J: Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorumsensing signaling molecules. J Bacteriol 2010; 192: 1946-1955.
29. Moyed HS, Bertrand KP: HipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 1983; 155: 768-775.
30. Mukamolova GV, Kaprelyants AS, Young DI, Young M, Kell DB: A bacterial cytokine. Proc Natl Acad Sci USA 1998; 95: 8916-8921.
31. Proctor RA, von Eiff C, Kahl BC, Becker K, Mc- Namara P, Herrmann M, Peters G: Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 2006; 4: 295-305.
32. Shah D, Zhang Z, Khodursky A, Kaldalu N, Kurg K, Lewis K: Persisters: a distinct physiological state of E. coli . BMC Microbiol 2006; 6: 53.
33. Shapiro JA, Nguyen VL, Chamberlain NR: Evidence for persisters in Staphylococcus epidermidis RP62A planktonic cultures and biofilms. J Med Microbiol 2011; 60: 950-960.
34. Singh R, Ray P, Das A, Sharma M: Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus : an in vitro study. J Med Microbiol 2009; 58: 1067-1073.
35. Tuchscherr L, Medina E, Hussain M, Völker W, Heitmann V, Niemann S, Holzinger D, Roth J, Proctor RA, Becker K, Peters G, Löffler B: Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med 2011; 3: 129-141.
36. Vazquez-Laslop N, Lee H, Neyfakh AA: Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J Bacteriol 2006; 188: 3494-3497.
37. von Eiff C: Staphylococcus aureus small colony variants: a challenge to microbiologists and clinicians. Int J Antimicrob Agents 2008; 31: 507-510.
38. Wiuff C, Zappala RM, Regoes RR, Garner KN, Baquero F, Levin BR: Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations. Antimicrob Agents Chemother 2005; 49: 1483-1494.